1. Hospital episode-of-care costs for hip fractures: an activity-based costing analysis
- Author
-
Antoine Denis, MD, Julien Montreuil, MD, MSc, Yasser Bouklouch, BS, MPH, Rudolf Reindl, MD, FRCSC, Gregory K. Berry, MDCM, MSEd, FRCSC, Edward J. Harvey, HBSc, MSc, MDCM, FRCSC, and Mitchell Bernstein, MD, FRCSC
- Subjects
Orthopedic surgery ,RD701-811 - Abstract
Background:. Despite the large impact of hip fracture care on hospital budgets, accurate episode-of-care costs (EOCC) calculations for this injury remains a challenge. The objective of this article was to assess EOCC for geriatric patients with hip fractures using an activity-based costing methodology and identify intraoperative, perioperative, and patient-specific factors associated with higher EOCC. Material and Methods:. This is a retrospective cohort study involving a total of 109 consecutive patients with hip fracture treated surgically at a Canadian level-1 trauma center from April 2018 to February 2019. Clinical and demographic data were extracted through the institution's centralized data warehouse. Data acquisition also included direct and indirect costs per episode of care, adverse events, and precise temporal data. Results:. The median total EOCC was $13,113 (interquartile range 6658), excluding physician fees. Out of the total cost, 75% was attributed to direct costs, which represented a median expenditure of $9941. The median indirect cost of the EOCC was $3322. Based on the multivariate analysis, patients not operated within the 48 hours guidelines had an increased length of stay by 5.7 days (P = 0.003), representing an increase in EOCC of close to 5000$. Higher American Society of Anesthesiology (ASA) scores were associated with elevated EOCC. Conclusion:. The cost of managing a patient with geriatric hip fracture from arrival in the emergency department to discharge from surgical ward represented $13,113. Main factors influencing the EOCC included adherence to the 48-hour benchmark surgical delay and ASA score. High-quality costing data are vital in assessing health care spending, conducting cost effectiveness analyses, and ultimately in guiding policy decisions. Level of Evidence:. Level III (3), retrospective cohort study.
- Published
- 2023
- Full Text
- View/download PDF